News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search


PHARMAC disappointed drug promoted

22 December 2004

PHARMAC disappointed drug promoted despite potential side-effects

PHARMAC is calling for drug companies to act more swiftly when concerns are raised over potential side effects and to be responsible in the promotion of their drugs.

The call follows reports that show arthritis drug Celebrex, a Cox-2 Inhibitor, more than doubles the risk of heart attacks and strokes. The latest findings follow the international withdrawal two months ago of another Cox-2 Inhibitor Vioxx due to similar side effects.

PHARMAC Chief Executive Wayne McNee says it was disappointing that Pfizer continued to aggressively promote Celebrex to doctors despite the withdrawal of Vioxx and similar concerns being raised about its own drug.

“A United States study raised concerns about Celebrex, and as a result the Food and Drug Administration asked Pfizer to voluntarily withdraw its advertising. However, it is concerning that despite this request, Pfizer has said that it will continue to promote the product to doctors.

“It is difficult to comprehend how a company can justify continuing to promote the safety of these drugs, and to claim there is no increased risk of cardiovascular events.”

Wayne McNee says the safety concerns around these drugs have been known for at least four years. PHARMAC decided in January not to fund Cox-2 Inhibitors based on the evidence of potential risk to patients.

“Drug companies must take these concerns very seriously, and it is irresponsible for them to continue to promote the benefits of drugs and ignoring the potential risks.”

He says when making the funding decision PHARMAC concluded that there was no evidence the COX-2 Inhibitors worked better than the older medicines.

“This shows clearly that new is not always better. Patient safety is always an important part of our decision making and in this case there were clear question marks over the side effects of these drugs.”


© Scoop Media

Culture Headlines | Health Headlines | Education Headlines


Electronica: Restoring The World’s First Recorded Computer Music

University of Canterbury Distinguished Professor Jack Copeland and UC alumni and composer Jason Long have restored the earliest known recording of computer-generated music, created more than 65 years ago using programming techniques devised by Alan Turing. More>>


Scoop Review Of Books: Almost Getting Away With Murder

The Black Widow by Lee-Anne Cartier: Lee-Anne Cartier is the sister of the Christchurch man found to have been murdered by his wife, Helen Milner, after an initial assumption by police that his death, in 2009, was suicide. More>>

Howard Davis: Triple Echo - The Malevich/Reinhardt/Hotere Nexus

Howard Davis: The current juxtaposition of works by Ralph Hotere and Ad Reinhardt at Te Papa perfectly exemplifies Jean Michel Massing's preoccupation with the transmigration of imagery in a remarkable triple echo effect... More>>

Scoop Review Of Books: Nō Tāu Manawa

Vaughan Rapatahana responds to Fale Aitu | Spirit House by Tusiata Avi: "fa’afetai Tusiata, fa’afetai, / you’ve swerved & served us a masterclass corpus / through graft / of tears & fears..." More>>

9 Golds - 21 Medals: NZ Team Celebrates As Rio 2016 Paralympic Games Close

The entire New Zealand Paralympic Team, led by kiwi sprinter and double gold medallist Liam Malone as flag bearer, are on the bus to the Maracanã Stadium in Rio de Janeiro for the Closing Ceremony of the Rio 2016 Paralympic Games. There, they will celebrate the fantastic successes of the past 10 days. More>>


New Zealand Improv Festival: The Festival Of Moments To Return To The Capital

The eighth incarnation of the New Zealand Improv Festival comes to BATS Theatre this 4-8 October , with a stellar line-up of spontaneous theatre and instant comedy performed and directed by top improvisors from around New Zealand and the world. More>>


Get More From Scoop



Search Scoop  
Powered by Vodafone
NZ independent news